Catalyst
Slingshot members are tracking this event:
Sunovion Announces Publication of Data Evaluating Dose Escalation of Latuda (lurasidone HCl) in the Treatment of Schizophrenia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Sunovion Pharmaceuticals |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Lurasidone Hci, Latuda, Schizophrenia
